Characterization of monoclonal antibody recognizing ERCC1 overexpression, a potential biomarker for cisplatin response

被引：0
|
作者：
Oishi, Takayuki [1 ]
Sasaki, Yuka [2 ]
Tong, Ying
Chen Lichao
Onodera, Takae [2 ]
Iwasa, Satoru
Udo, Emiko
Furusato, Bungo
Nakao, Kazuhiko
Yamada, Yasuhide
Hiraoka, Nobuyoshi
Masutani, Mitsuko [2 ]
机构：
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Genom Biomed, Nagasaki, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol & Genom BioMed, Nagasaki, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PJ17-2-3
引用
收藏
页码：915 / 915
页数：1
相关论文
共 50 条
  • [41] ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines
    Li, Wei
    Jie, ZhiGang
    Li, Zhengrong
    Liu, Yi
    Gan, Quan
    Mao, Yiqiu
    Wang, Xuemin
    MOLECULAR MEDICINE REPORTS, 2014, 9 (06) : 2423 - 2428
  • [42] Participation of ERCC1 in resistance against cisplatin for human esophageal cancer cell lines
    Miyahara, T
    Yanagihashi, K
    Kajiwara, T
    Akaboshi, M
    Kawabe, A
    Kaganoi, JI
    PROCEEDINGS OF THE 37TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 2002, : 195 - 199
  • [43] ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells
    Britten, RA
    Liu, D
    Tessier, A
    Hutchison, MJ
    Murray, D
    INTERNATIONAL JOURNAL OF CANCER, 2000, 89 (05) : 453 - 457
  • [44] ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
    Jong-Mu Sun
    Ji-Youn Sung
    Se Hoon Park
    Ghee Young Kwon
    Byong Chang Jeong
    Seong Il Seo
    Seong Soo Jeon
    Hyun Moo Lee
    Jisuk Jo
    Han Yong Choi
    Ho Yeong Lim
    BMC Cancer, 12
  • [45] ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
    Sun, Jong-Mu
    Sung, Ji-Youn
    Park, Se Hoon
    Kwon, Ghee Young
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Jo, Jisuk
    Choi, Han Yong
    Lim, Ho Yeong
    BMC CANCER, 2012, 12
  • [46] Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
    Smith, David Hersi
    Fiehn, Anne-Marie Kanstrup
    Fogh, Louise
    Christensen, Ib Jarle
    Hansen, Tine Plato
    Stenvang, Jan
    Nielsen, Hans Jorgen
    Nielsen, Kirsten Vang
    Hasselby, Jane Preuss
    Brunner, Nils
    Jensen, Sussie Steen
    SCIENTIFIC REPORTS, 2014, 4
  • [47] Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)
    Lee, Siow Ming
    Falzon, Mary
    Blackhall, Fiona
    Spicer, James
    Nicolson, Marianne
    Chaudhuri, Abhro
    Middleton, Gary
    Ahmed, Samreen
    Hicks, Jonathan
    Crosse, Barbara
    Napier, Mark
    Singer, Julian M.
    Ferry, David
    Lewanski, Conrad
    Forster, Martin
    Rolls, Sally-Ann
    Capitanio, Arrigo
    Rudd, Robin
    Iles, Natasha
    Ngai, Yenting
    Gandy, Michael
    Lillywhite, Rachel
    Hackshaw, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 402 - +
  • [48] ERCC1 EXPRESSION AS PREDICTIVE BIOMARKER FOR PLATINUM CONTAINING CHEMOTHERAPY REGIMENS IN OVARIAN CARCINOMA
    Ulker, M.
    Duman, B. B.
    Sahin, B.
    Gumurdulu, D.
    ANNALS OF ONCOLOGY, 2012, 23 : 326 - 326
  • [49] ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy
    Klatte, Tobias
    Seitz, Christian
    Rink, Michael
    Roupret, Morgan
    Xylinas, Evanguelos
    Karakiewicz, Pierre
    Susani, Martin
    Shariat, Shahrokh F.
    JOURNAL OF UROLOGY, 2015, 194 (05): : 1456 - 1462
  • [50] Non-small cell lung cancers:: ERCC1, a therapeutic biomarker in view
    Benard, Jean
    BULLETIN DU CANCER, 2006, 93 (11) : 1086 - 1086
12345